A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways

Louise C Druedahl; Anna Birna Almarsdóttir; Sofia Kälvemark Sporrong; Marie Louise De Bruin; Hans Hoogland; Timo Minssen; Marco van de Weert; Aaron S Kesselheim; Ameet Sarpatwari

doi:10.1038/s41587-020-0717-7

A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways

Louise C Druedahl, Anna Birna Almarsdóttir, Sofia Kälvemark Sporrong, Marie Louise De Bruin, Hans Hoogland, Timo Minssen, Marco van de Weert, Aaron S Kesselheim, Ameet Sarpatwari^*

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

19 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Nature Biotechnology
Vol/bind	38
Udgave nummer	11
Sider (fra-til)	1253-1256
Antal sider	4
ISSN	1087-0156
DOI	https://doi.org/10.1038/s41587-020-0717-7
Status	Udgivet - 2020

Adgang til dokumentet

10.1038/s41587-020-0717-7

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Forsker: Jura står i vejen for biosimilært potentiale
Druedahl, L. C.
19/03/2021
1 Mediebidrag
Presse/medie
Scientific, legal and regulatory challenges facing biosimilars development
Druedahl, L. C.
11/12/2020
1 Mediebidrag
Presse/medie

Citationsformater

Druedahl, L. C., Almarsdóttir, A. B., Kälvemark Sporrong, S., De Bruin, M. L., Hoogland, H., Minssen, T., van de Weert, M., Kesselheim, A. S., & Sarpatwari, A. (2020). A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways. Nature Biotechnology, 38(11), 1253-1256. https://doi.org/10.1038/s41587-020-0717-7

Druedahl, LC, Almarsdóttir, AB, Kälvemark Sporrong, S, De Bruin, ML, Hoogland, H, Minssen, T , van de Weert, M, Kesselheim, AS & Sarpatwari, A 2020, 'A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways', Nature Biotechnology, bind 38, nr. 11, s. 1253-1256. https://doi.org/10.1038/s41587-020-0717-7

@article{3f758d7c1cc54739bb14a0b49c7b381e,

title = "A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways",

author = "Druedahl, {Louise C} and Almarsd{\'o}ttir, {Anna Birna} and {K{\"a}lvemark Sporrong}, Sofia and {De Bruin}, {Marie Louise} and Hans Hoogland and Timo Minssen and {van de Weert}, Marco and Kesselheim, {Aaron S} and Ameet Sarpatwari",

year = "2020",

doi = "10.1038/s41587-020-0717-7",

language = "English",

volume = "38",

pages = "1253--1256",

journal = "Nature Biotechnology",

issn = "1087-0156",

publisher = "nature publishing group",

number = "11",

}

TY - JOUR

T1 - A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways

AU - Druedahl, Louise C

AU - Almarsdóttir, Anna Birna

AU - Kälvemark Sporrong, Sofia

AU - De Bruin, Marie Louise

AU - Hoogland, Hans

AU - Minssen, Timo

AU - van de Weert, Marco

AU - Kesselheim, Aaron S

AU - Sarpatwari, Ameet

PY - 2020

Y1 - 2020

U2 - 10.1038/s41587-020-0717-7

DO - 10.1038/s41587-020-0717-7

M3 - Journal article

C2 - 33144720

SN - 1087-0156

VL - 38

SP - 1253

EP - 1256

JO - Nature Biotechnology

JF - Nature Biotechnology

IS - 11

ER -

A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways

Adgang til dokumentet

Biblioteksadgang?

Presse/Medier

Forsker: Jura står i vejen for biosimilært potentiale

Scientific, legal and regulatory challenges facing biosimilars development

Citationsformater